412 related articles for article (PubMed ID: 22432619)
1. Crystal polymorphism in chemical process development.
Lee AY; Erdemir D; Myerson AS
Annu Rev Chem Biomol Eng; 2011; 2():259-80. PubMed ID: 22432619
[TBL] [Abstract][Full Text] [Related]
2. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
Erdemir D; Lee AY; Myerson AS
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
[TBL] [Abstract][Full Text] [Related]
3. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
[TBL] [Abstract][Full Text] [Related]
4. Solid form screening--a review.
Aaltonen J; Allesø M; Mirza S; Koradia V; Gordon KC; Rantanen J
Eur J Pharm Biopharm; 2009 Jan; 71(1):23-37. PubMed ID: 18715549
[TBL] [Abstract][Full Text] [Related]
5. [Advances in the quantitative analytical methods of drug polymorphism].
Ma LW; Du W; Zhao CS
Yao Xue Xue Bao; 2011 Aug; 46(8):896-903. PubMed ID: 22007512
[TBL] [Abstract][Full Text] [Related]
6. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
Reutzel-Edens SM
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
[TBL] [Abstract][Full Text] [Related]
7. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.
Pasquali I; Bettini R; Giordano F
Adv Drug Deliv Rev; 2008 Feb; 60(3):399-410. PubMed ID: 17964684
[TBL] [Abstract][Full Text] [Related]
8. Selecting and controlling API crystal form for pharmaceutical development--strategies and processes.
Yin SX; Grosso JA
Curr Opin Drug Discov Devel; 2008 Nov; 11(6):771-7. PubMed ID: 18946842
[TBL] [Abstract][Full Text] [Related]
9. Applications of process analytical technology to crystallization processes.
Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
[TBL] [Abstract][Full Text] [Related]
10. Solid state amorphization of pharmaceuticals.
Willart JF; Descamps M
Mol Pharm; 2008; 5(6):905-20. PubMed ID: 18954076
[TBL] [Abstract][Full Text] [Related]
11. [Crystallization and solid state properties of molecules of pharmaceutical interest].
Bauer M
Ann Pharm Fr; 2002 May; 60(3):152-60. PubMed ID: 12050594
[TBL] [Abstract][Full Text] [Related]
12. The solid-state continuum: a perspective on the interrelationships between different solid-state forms in drug substance and drug product.
Elder DP; Patterson JE; Holm R
J Pharm Pharmacol; 2015 Jun; 67(6):757-72. PubMed ID: 25124049
[TBL] [Abstract][Full Text] [Related]
13. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
Almarsson O; Zaworotko MJ
Chem Commun (Camb); 2004 Sep; (17):1889-96. PubMed ID: 15340589
[TBL] [Abstract][Full Text] [Related]
14. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
Heinz A; Strachan CJ; Gordon KC; Rades T
J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
[TBL] [Abstract][Full Text] [Related]
15. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.
Ticehurst MD; Marziano I
J Pharm Pharmacol; 2015 Jun; 67(6):782-802. PubMed ID: 25677227
[TBL] [Abstract][Full Text] [Related]
16. The role of co-crystals in pharmaceutical design.
Steed JW
Trends Pharmacol Sci; 2013 Mar; 34(3):185-93. PubMed ID: 23347591
[TBL] [Abstract][Full Text] [Related]
17. Applications of solid-state NMR to pharmaceutical polymorphism and related matters.
Harris RK
J Pharm Pharmacol; 2007 Feb; 59(2):225-39. PubMed ID: 17270076
[TBL] [Abstract][Full Text] [Related]
18. Formulation of tablets containing an 'in-process' amorphized active pharmaceutical ingredient.
Jójárt-Laczkovich O; Szabó-Révész P
Drug Dev Ind Pharm; 2011 Nov; 37(11):1272-81. PubMed ID: 21457129
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pharmaceutically relevant materials at the solid state employing chemometrics methods.
Calvo NL; Maggio RM; Kaufman TS
J Pharm Biomed Anal; 2018 Jan; 147():538-564. PubMed ID: 28666554
[TBL] [Abstract][Full Text] [Related]
20. Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids.
Shah B; Kakumanu VK; Bansal AK
J Pharm Sci; 2006 Aug; 95(8):1641-65. PubMed ID: 16802362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
